This year, there’s a lot of excitement around 4/20, as the cannabis holiday falls on a Saturday, which means customers will have more time to shop around and stock up on deals. As cannabis comes closer to mainstream and legalization in the U.S. has more support than ever, more cannabis products have emerged. This year, while flower will still dominate sales, experts also anticipate that edibles and beverages will get a lot of attention, especially among new or occasional consumers. With this...

U.S. cannabis dispensary operator MedMen Enterprises Inc MMNFF 5.3% said Friday that it accepted the resignations of Ben Cook, its chief operating officer, and Lisa Sergi, its general counsel and a board member. The company said it appointed Ryan Lissack as chief technology officer. The management changes were announced four days after the company reported its preliminary results for the fiscal third quarter. What Happened The appointment of Lissack as CTO took place during the fiscal third...

Harvest Health & Recreation Inc HRVSF 5.54% reported fourth-quarter financial results Tuesday that include revenue growth of 135 percent on the year and 52 percent sequentially. What Happened The multistate cannabis company's revenue totaled $16.9 million in the quarter ended Dec. 31. Its gross profit, excluding the impact of biological assets, amounted to $7.2 million, up from $1.6 million a year earlier. Harvest Health & Recreation also posted a net loss of $71.1 million, including a...

Multistate cannabis operator Cresco Labs CRLBF 7.33% reported fourth-quarter financial results Wednesday that included revenue growth of 411 percent on the year. What Happened Chicago-based Cresco posted revenue of $17 million, up by 33 percent sequentially, and a net loss of $2.3 million versus a loss of $3 million in the fourth quarter of 2017. The pro forma revenue — which includes acquisitions entered into and closed during the fourth quarter — totaled $22.5 million. The company's...

Canadian cannabis producer Aurora Cannabis Inc ACB 0.66% said Thursday that it entered into a binding share purchase agreement to acquire Ontario-based laboratory operator Chemi Pharmaceutical. What Happened The acquisition will be conducted in cash and stock. Aurora did not disclose the amount, but said it would pay Chemi Pharmaceutical shareholders 83,299 shares on closing, which equates to roughly $750,000. Aurora said it will pay an additional 41,649 shares upon achievement of certain...